Summary of Significant Accounting Policies (Tables)

12 Months Ended

Feb. 03, 2024

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents in the Consolidated Balance Sheets that reconcile to the amounts shown on the Consolidated Statements of Cash Flows:

($000)	2023		2022		2021
Cash and cash equivalents	$	4,872,446	$	4,551,876	$	4,922,365
Restricted cash and cash equivalents included in:
Prepaid expenses and other	14,489		12,677		11,403
Other long-term assets	48,506		47,688		48,614
Total restricted cash and cash equivalents	62,995		60,365		60,017
Total cash and cash equivalents, and restricted cash and cash equivalents	$	4,935,441	$	4,612,241	$	4,982,382

Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents in the Consolidated Balance Sheets that reconcile to the amounts shown on the Consolidated Statements of Cash Flows:

($000)	2023		2022		2021
Cash and cash equivalents	$	4,872,446	$	4,551,876	$	4,922,365
Restricted cash and cash equivalents included in:
Prepaid expenses and other	14,489		12,677		11,403
Other long-term assets	48,506		47,688		48,614
Total restricted cash and cash equivalents	62,995		60,365		60,017
Total cash and cash equivalents, and restricted cash and cash equivalents	$	4,935,441	$	4,612,241	$	4,982,382

Schedule of Other Long-Term Assets

Other long-term assets as of February 3, 2024 and January 28, 2023 consisted of the following:

($000)	2023		2022
Deferred compensation (Note G)	$	165,582	$	155,496
Restricted cash and cash equivalents	48,506		47,688
Other	29,141		28,899
Total	$	243,229	$	232,083

Summary of Insurance Obligations

Self-insurance and deductible reserves as of February 3, 2024 and January 28, 2023 consisted of the following:

($000)	2023		2022
Workers’ compensation	$	80,791	$	80,275
General liability	47,663		48,754
Medical plans	8,145		9,650
Total	$	136,599	$	138,679

Schedule of Other Long-Term Liabilities

Other long-term liabilities as of February 3, 2024 and January 28, 2023 consisted of the following:

($000)	2023		2022
Income taxes (Note F)	$	56,045	$	57,409
Deferred compensation (Note G)	165,582		155,496
Other	10,756		11,199
Total	$	232,383	$	224,104

Schedule of Disaggregation of Revenue

The following sales mix table disaggregates revenue by merchandise category for fiscal 2023, 2022, and 2021:

	2023		1	2022		2021
Home Accents and Bed and Bath	26	%		26	%	26	%
Ladies	23	%		24	%	25	%
Men’s	15	%		15	%	14	%
Accessories, Lingerie, Fine Jewelry, and Cosmetics	15	%		14	%	14	%
Shoes	13	%		12	%	12	%
Children’s	8	%		9	%	9	%
Total	100	%		100	%	100	%

Schedule of Basic and Diluted EPS

The following is a reconciliation of the number of shares (denominator) used in the basic and diluted EPS computations:

Shares in (000s)	Basic EPS		Effect of dilutive common stock equivalents		Diluted EPS
2023
Shares	335,187		2,246		337,433
Amount	$	5.59	$	(0.03)	$	5.56
2022
Shares	343,452		1,770		345,222
Amount	$	4.40	$	(0.02)	$	4.38
2021
Shares	351,496		2,238		353,734
Amount	$	4.90	$	(0.03)	$	4.87